- Home
- CAMT vs VKTX Comparison
CAMT vs VKTX Comparison
Compare CAMT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- VKTX
- Stock Information
- Founded
- CAMT 1987
- VKTX 2012
- Country
- CAMT Israel
- VKTX United States
- Employees
- CAMT N/A
- VKTX N/A
- Industry
- CAMT Electronic Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CAMT Technology
- VKTX Health Care
- Exchange
- CAMT Nasdaq
- VKTX Nasdaq
- Market Cap
- CAMT 3.0B
- VKTX 2.8B
- IPO Year
- CAMT 2000
- VKTX 2015
- Fundamental
- Price
- CAMT $73.95
- VKTX $26.01
- Analyst Decision
- CAMT Strong Buy
- VKTX Buy
- Analyst Count
- CAMT 9
- VKTX 12
- Target Price
- CAMT $92.44
- VKTX $84.00
- AVG Volume (30 Days)
- CAMT 293.0K
- VKTX 2.9M
- Earning Date
- CAMT 07-31-2025
- VKTX 07-23-2025
- Dividend Yield
- CAMT N/A
- VKTX N/A
- EPS Growth
- CAMT 46.65
- VKTX N/A
- EPS
- CAMT 2.61
- VKTX N/A
- Revenue
- CAMT $450,862,000.00
- VKTX N/A
- Revenue This Year
- CAMT $16.33
- VKTX N/A
- Revenue Next Year
- CAMT $8.53
- VKTX N/A
- P/E Ratio
- CAMT $28.70
- VKTX N/A
- Revenue Growth
- CAMT 32.63
- VKTX N/A
- 52 Week Low
- CAMT $47.41
- VKTX $18.92
- 52 Week High
- CAMT $140.50
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- CAMT 57.33
- VKTX 44.01
- Support Level
- CAMT $70.07
- VKTX $25.61
- Resistance Level
- CAMT $76.13
- VKTX $30.17
- Average True Range (ATR)
- CAMT 2.54
- VKTX 1.43
- MACD
- CAMT 0.13
- VKTX -0.21
- Stochastic Oscillator
- CAMT 72.46
- VKTX 9.76
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.